Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

Toronto Metropolitan University

$27,000.00

The Impact of Glucagon-Like Peptide-1 Agonists on Dementia Risk in South Asian Populations

EF 2024-25

Résumé
The number of people living with dementia in Canada is growing rapidly. Previous research has shown that the risk of developing dementia is higher in South Asian populations and women, with factors such as diabetes and hypertension contributing to this elevated risk. South Asian populations are at higher risk for diabetes at a younger age compared to White populations. Women are at higher risk for diabetes-related cardiovascular events compared to men. While progress has been made in identifying such risk factors, prevention efforts have been limited to improving awareness of dementia in South Asian communities. Glucagon-Like Peptide-1 (GLP-1) agonists have emerged as effective drugs in managing diabetes and diabetes-related cardiovascular events, particularly in South Asian populations. A recent study has also shown an association between GLP-1 agonist use and reduction of dementia risk, making this the ideal candidate for dementia prevention in South Asian populations. My aims are twofold- 1) To explore the impact of GLP-1 agonist use on dementia risk in South Asian populations, and 2) To explore the impacts of sex and gender on GLP-1 agonist use and dementia risk. The proposed research will provide insight into the effectiveness of GLP-1 agonist use on dementia risk reduction in South Asian communities, which will be crucial to developing population-specific dementia interventions. This research will also provide insight into the intersectional impacts of ethnicity, sex, and gender on dementia risk and prevention, further contributing to the development of personalized medicine for at-risk groups.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530345
Name
Ramana Shreeyaa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Impact of Glucagon-Like Peptide-1 Agonists on Dementia Risk in South Asian Populations
Programtype2
Studentship Programs
Orgnameinp2
Toronto Metropolitan University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Dementia Risk; Ethnocultural Diversity; Sex And Gender Science
Abstract
The number of people living with dementia in Canada is growing rapidly. Previous research has shown that the risk of developing dementia is higher in South Asian populations and women, with factors such as diabetes and hypertension contributing to this elevated risk. South Asian populations are at higher risk for diabetes at a younger age compared to White populations. Women are at higher risk for diabetes-related cardiovascular events compared to men. While progress has been made in identifying such risk factors, prevention efforts have been limited to improving awareness of dementia in South Asian communities. Glucagon-Like Peptide-1 (GLP-1) agonists have emerged as effective drugs in managing diabetes and diabetes-related cardiovascular events, particularly in South Asian populations. A recent study has also shown an association between GLP-1 agonist use and reduction of dementia risk, making this the ideal candidate for dementia prevention in South Asian populations. My aims are twofold- 1) To explore the impact of GLP-1 agonist use on dementia risk in South Asian populations, and 2) To explore the impacts of sex and gender on GLP-1 agonist use and dementia risk. The proposed research will provide insight into the effectiveness of GLP-1 agonist use on dementia risk reduction in South Asian communities, which will be crucial to developing population-specific dementia interventions. This research will also provide insight into the intersectional impacts of ethnicity, sex, and gender on dementia risk and prevention, further contributing to the development of personalized medicine for at-risk groups.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ramana, Shreeyaa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~